title: The response of corticotropin and adrenal steroids to desmopressin stimulation in patients with various forms of hypercortisolism.
abstract: OBJECTIVE
  The purpose of this study was to evaluate the direct action of desmopressin (agonist of vasopressin) on the hypophysis and the three zones of the adrenal cortex in patients with different forms of hypercortisolism.
  
  
  METHODS
  Forty-three patients with hypercortisolism-21 with Cushing's disease (14 females, 7 males), 11 with extrapituitary, ectopic tumours (5 females, 6 males), and 11 with ACTH-independent Cushing's syndrome (6 females, 5 males)-were evaluated. The response of the pituitary and adrenal glands was assessed by measuring plasma levels of adrenocorticotropic hormone (ACTH), cortisol, aldosterone, and dehydroepiandrosterone sulfate (DHEAS) at baseline and at 15, 30, 60, 90, and 120 min after the administration of desmopressin.
  
  
  RESULTS
  We observed two main modes of secretory response: (1) elevation of the ACTH level followed by a rise of one, two or all three adrenal steroids, and (2) ACTH-independent elevation of adrenal steroids in various combinations.
  
  
  CONCLUSIONS
  In a number of patients with hypercortisolism, the adrenal cortex responded to desmopressin administration by enhanced synthesis and secretion of glucocorticoids (cortisol), mineralocorticoids (aldosterone), and adrenal androgens (DHEAS) without a concomitant rise in ACTH. These findings suggest the presence of "ectopic" vasopressin receptors in the human adrenal cortex.
authors.affiliation: National Research Center for Endocrinology of the Russian Academy of Medical Sciences, Moscow, Russia.
authors.forename: Eugenia I
authors.initials: EI
authors.lastname: Marova
authors.forename: Nikolay P
authors.initials: NP
authors.lastname: Goncharov
authors.forename: Galina S
authors.initials: GS
authors.lastname: Kolesnikova
authors.forename: Svetlana D
authors.initials: SD
authors.lastname: Arapova
authors.forename: Anastasiya M
authors.initials: AM
authors.lastname: Lapshina
mesh_terms: D000302:Adrenal Cortex / Q000187:drug effects* / Q000378:metabolism; D000305:Adrenal Cortex Hormones / Q000097:blood*; D000324:Adrenocorticotropic Hormone / Q000097:blood*; D000328:Adult; D000450:Aldosterone / Q000097:blood; D002940:Circadian Rhythm; D003480:Cushing Syndrome / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism*; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology*; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010913:Pituitary-Adrenal System / Q000187:drug effects* / Q000378:metabolism; D013997:Time Factors
chemical_list: D000305:Adrenal Cortex Hormones; D000450:Aldosterone; D019314:Dehydroepiandrosterone Sulfate; D000324:Adrenocorticotropic Hormone; D003894:Deamino Arginine Vasopressin; D006854:Hydrocortisone